CMV PCR, Qualitative, Plasma

CMV PCR, Qualitative, Plasma

The CMV PCR Qualitative Test is a molecular diagnostic test used to detect the presence of Cytomegalovirus (CMV) DNA in plasma samples. This test helps identify active CMV infection, especially in immunocompromised individuals and transplant patients.

Test Principle

The test uses Polymerase Chain Reaction (PCR) technology to amplify and detect CMV genetic material in plasma with high sensitivity and specificity.

Specimen

• Plasma

Purpose of the Test

• Detect active CMV infection
• Early diagnosis in immunocompromised patients
• Monitor transplant recipients
• Support diagnosis in congenital CMV infection
• Evaluate unexplained fever or viral symptoms

Common Indications

• Organ transplant monitoring
• HIV/AIDS patients
• Patients on immunosuppressive therapy
• Neonatal CMV screening
• Suspected CMV reactivation

Advantages

• Highly sensitive molecular detection
• Early identification before symptoms worsen
• Rapid and reliable results
• Helps guide antiviral therapy decisions

Method

• Real-Time PCR / Qualitative PCR

Interpretation

• Detected: CMV DNA present
• Not Detected: CMV DNA absent or below detection limit

Turnaround Time

• Usually 24–72 hours depending on laboratory processing

Precautions

• Proper plasma collection and storage required
• Clinical correlation recommended for interpretation